Placentia, CA – June 30, 2025 — Applied Biomedicals is honored to announce the appointment of Dr. Roscoe M. Moore, Jr., D.V.M., Ph.D., D.Sc. (Hon.) to its Executive Board, further strengthening the company’s leadership in global health strategy, translational diagnostics, and evidence-based medical innovation.

Applied Biomedicals is honored to announce the appointment of Dr. Roscoe M. Moore, Jr., D.V.M., Ph.D., D.Sc. (Hon.) to its Executive Board, further strengthening the company’s leadership in global health strategy, translational diagnostics, and evidence-based medical innovation.

Dr. Moore brings a distinguished public health career spanning over four decades, including his role as Assistant United States Surgeon General and Rear Admiral in the U.S. Public Health Service (USPHS). Until his retirement, Dr. Moore served within the U.S. Department of Health and Human Services (HHS), where he was the principal official for global development support, with a special focus on health infrastructure in Africa and developing regions across Asia and the Caribbean.

As the former Chief Veterinary Medical Officer for the USPHS and Senior Epidemiologist with both the CDC and the FDA, Dr. Moore is internationally regarded for his pioneering contributions to medical device epidemiology, infectious disease control, vaccine evaluation, and public health preparedness. He is credited with founding the FDA’s first epidemiological fellowship in medical device safety and is widely acknowledged as the “Father” of Medical Device Epidemiology.

“Dr. Moore’s breadth of experience in international public health policy, biomedical innovation, and regulatory science is unparalleled,” said [Name], CEO of Applied Biomedicals. “His guidance will be pivotal as we expand our global footprint and develop technologies that address the pressing health needs of underserved populations.”

Dr. Moore holds degrees in veterinary medicine, public health, and epidemiology from Tuskegee University, the University of Michigan, and the Johns Hopkins Bloomberg School of Public Health, where he was also honored with a Doctor of Science degree. His scientific and policy influence spans six continents, where he has contributed to sustainable disease surveillance, diagnostic innovation, and biosecurity strategy.

Currently, Dr. Moore serves on numerous scientific and corporate advisory boards, including Immunomic Therapeutics, ImQuest Life Sciences, HemoBioTech, Cannabis Science, and Biodefense Gamma LLC. He is the Founder and President of PH RockWood Corporation, and a Senior Fellow at the Potomac Institute for Policy Studies.

He has authored over 100 scientific publications and held advisory positions with institutions such as the NIH Fogarty International Center, Johns Hopkins, University of Michigan, George Washington University, and the University of Hanoi. His contributions to public health have been recognized globally, including gubernatorial appointments, board leadership roles, and honors for his service to health and humanitarian causes.

With this appointment, Applied Biomedicals is proud to align with Dr. Moore’s lifelong mission to advance health equity, scientific rigor, and global health resilience through innovation and collaboration.